LOXL2 and hepatocellular carcinoma: Moreover, TGFβ treatment also increases the expression of lysyl oxidase like 2 (LOXL2) in hepatocellular carcinoma cell cultures [32], and lysyl hydroxylase 2b (LH2b) in human synovial osteoarthritic fibroblast cultures [33].